Monday, October 24, 2016

Nestabs DHA Prenatal




Generic Name: multi-vitamin/mineral supplement

Dosage Form: tablet, film coated
NESTABS DHA Prenatal Multi-vitamin/Mineral Tablet

Descripton:   Nestabs DHA combination tablet-capsule for oral administration is a light pink capsule-shaped film coated tablet with a pleasant sweet flavor with WCOO1 imprinted on one side of the tablet and a enteric coated light amber soft gel capsule omega-3 fatty acid containing both DHA and EPA.



Indications and Usage: Nestabs DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Nestabs DHA is also beneficial in improving the nutritional status of women prior to conception.



Contraindications:  This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .



Warnings:  Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.




Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.






WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.




Precautions:  Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. This product contains formate, which if consumed above the recommended level, could cause visual impairment and other health effects. Do not take more than the recommended amount. If you are pregnant, nursing, or taking any medications consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur. Not intended for use by persons under the age of 18.



Adverse Reactions:  Allergic sensitization has been reported following both oral and parenteral administration of folic acid.



Dosage and Administration: Nestabs DHA - One tablet and one soft gel capsule daily or as directed by a physician.



How Supplied:  Nestabs DHA tablets for oral administration are supplied as six child-resistant blister cards containing 5 tablets and 5 softgel capsules each (NDC# 50967-317-30).

























NESTABS DHA  PRENATAL MULTI-VITAMIN/MINERAL SUPPLEMENT WITH DHA/EPA
sodium ascorbate, cholecalciferol, di-alpha-tocopheryl acetate, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hcl, folic acid, cyanocobalamin, calcium formate, calcium carbonate, ferrous (ii) bis-glycinate chelate, potassium iodide, zinc oxide, choline bitartrate, with doconexent and icosapent   kit






Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)50967-317














Packaging
#NDCPackage DescriptionMultilevel Packaging
150967-317-304 BLISTER PACK In 1 CARTONcontains a BLISTER PACK
11 KIT In 1 BLISTER PACKThis package is contained within the CARTON (50967-317-30)











QUANTITY OF PARTS
Part #Package QuantityTotal Product Quantity
Part 1 30 
Part 2 30 



Part 1 of 2
NESTABS  MULTI-VITAMIN/MINERAL SUPPLEMENT
sodium ascorbate, cholecalciferol, di-alpha-tocopheryl acetate, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hcl, folic acid, cyanocobalamin, calcium formate, calcium carbonate, ferrous (ii) bis-glycinate chelate, potassium iodide, zinc oxide, choline bitartrate  tablet










Product Information
   
Route of AdministrationORALDEA Schedule    


















































Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM ASCORBATE (ASCORBIC ACID)ASCORBIC ACID120 mg
CHOLECALCIFEROL (CHOLECALCIFEROL)CHOLECALCIFEROL450 [iU]
.ALPHA.-TOCOPHEROL ACETATE, D- (TOCOPHERSOLAN).ALPHA.-TOCOPHEROL ACETATE, D-30 [iU]
THIAMINE MONONITRATE (THIAMINE)THIAMINE3 mg
RIBOFLAVIN (RIBOFLAVIN)RIBOFLAVIN3 mg
NIACINAMIDE (NIACINAMIDE)NIACINAMIDE20 mg
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE)PYRIDOXINE50 mg
FOLIC ACID (FOLIC ACID)FOLIC ACID1 mg
CYANOCOBALAMIN (CYANOCOBALAMIN)CYANOCOBALAMIN10 ug
CALCIUM FORMATE (CALCIUM)CALCIUM155 mg
CALCIUM CARBONATE (CARBONATE ION)CARBONATE ION45 mg
FERROUS BISGLYCINATE (IRON)IRON32 mg
POTASSIUM IODIDE (POTASSIUM CATION)POTASSIUM CATION100 ug
ZINC OXIDE (ZINC)ZINC10 mg
CHOLINE BITARTRATE (CHOLINE)CHOLINE BITARTRATE55 mg






















Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE 
MAGNESIUM STEARATE 
POVIDONE 
POLYVINYL ALCOHOL 
TITANIUM DIOXIDE 
TALC 
FD&C RED NO. 40 
ALUMINUM OXIDE 
SACCHARIN 


















Product Characteristics
ColorpinkScoreno score
ShapeOVALSize18mm
FlavorImprint CodeWC;001
Contains      







Packaging
#NDCPackage DescriptionMultilevel Packaging
Package Information Not Applicable










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/01/2011




Part 2 of 2
NESTABS OMEGA 3-DHA  
doconexent and icosapent supplement   capsule, gelatin coated










Product Information
   
Route of AdministrationORALDEA Schedule    














Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCONEXENT (DOCONEXENT)DOCONEXENT230 mg
ICOSAPENT (ICOSAPENT)ICOSAPENT30 mg
ALPHA-TOCOPHEROL, D- (TOCOPHERSOLAN)ALPHA-TOCOPHEROL, D-2 [iU]










Inactive Ingredients
Ingredient NameStrength
GELATIN 
GLYCERIN 
WATER 


















Product Characteristics
ColoryellowScoreno score
ShapeOVALSize6mm
FlavorImprint Code;
Contains      







Packaging
#NDCPackage DescriptionMultilevel Packaging
Package Information Not Applicable










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/01/2011











Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/01/2011


Labeler - WOMENS CHOICE PHARMACEUTICALS LLC (833067841)

Registrant - WOMENS CHOICE PHARMACEUTICALS LLC (833067841)
Revised: 02/2011WOMENS CHOICE PHARMACEUTICALS LLC




More Nestabs DHA Prenatal resources


  • Nestabs DHA Prenatal Use in Pregnancy & Breastfeeding
  • Drug Images
  • Nestabs DHA Prenatal Drug Interactions
  • Nestabs DHA Prenatal Support Group
  • 21 Reviews for Nestabs DHA Prenatal - Add your own review/rating


Compare Nestabs DHA Prenatal with other medications


  • Vitamin/Mineral Supplementation during Pregnancy/Lactation

No comments:

Post a Comment